Jenks, J. D., Aslam, S., Horton, L. E., Law, N., Bharti, A., Logan, C., … COVID-19 Clinic Team, . (2022). Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19). Clin Infect Dis, 74(4), 752–753. https://doi.org/10.1093/cid/ciab522

Jenks, Jeffrey D., Saima Aslam, Lucy E. Horton, Nancy Law, Ajay Bharti, Cathy Logan, Mahnaz Taremi, Florin Vaida, Michele Ritter, and Michele COVID-19 Clinic Team. “Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19).” Clin Infect Dis 74, no. 4 (March 1, 2022): 752–53. https://doi.org/10.1093/cid/ciab522.

Jenks JD, Aslam S, Horton LE, Law N, Bharti A, Logan C, et al. Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 Mar 1;74(4):752–3.

Jenks, Jeffrey D., et al. “Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19).” Clin Infect Dis, vol. 74, no. 4, Mar. 2022, pp. 752–53. Pubmed, doi:10.1093/cid/ciab522.

Jenks JD, Aslam S, Horton LE, Law N, Bharti A, Logan C, Taremi M, Vaida F, Ritter M, COVID-19 Clinic Team. Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 Mar 1;74(4):752–753.